Company intelligence
Orogen Therapeutics
Pioneering transformative medicines through our AI-enabled DNA-encoded library platform for unmet medical needs.
About Orogen Therapeutics
Orogen Therapeutics is a biotechnology company advancing next-generation small molecule discovery through an AI-enabled DNA-encoded library (DEL) platform. By integrating computational intelligence with precision chemical diversity, we focus on identifying high-quality binders against challenging and high-value biological targets. Our platform is designed to concentrate chemical diversity around biologically relevant binding space, improving hit quality and accelerating the transition from discovery to development. This targeted approach enhances efficiency, reduces attrition risk, and supports the creation of differentiated therapeutic candidates. At Orogen, we are driven by a clear mission: to deliver transformative medicines for patients facing critical unmet medical needs.
Verified activity
Signals from Orogen Therapeutics
3 published signals
Research & Knowledge
Orogen Therapeutics reported promising preclinical data for its IL-17 program, showing that Orogen compounds demonstrate ~3× greater potency than competitors and deliver ~100× greater exposure in rodent plasma 8 hours after PO administration in the DC cohort.
Reported by Orogen Therapeutics
People
Orogen Therapeutics recognized Research Associate Jane Dubrovsky on the Biochemistry team.
Reported by Orogen Therapeutics
Presence & Recognition
Orogen Therapeutics Senior Research Scientist Harry Stern, PhD is presenting at the I Island² Chem Conference in Tenerife on September 2–4, 2026, titled Molecular Design with a Chemical Language Model.
Reported by Orogen Therapeutics